Nuveen New Competition

Funds . USA . 
Fund . Nuveen New York
NNY Fund  USD 8.40  0.03  0.36%   
Nuveen New York competes with MFS Investment, Eaton Vance, DTF Tax, HUMANA, and SCOR PK; as well as few others. The fund is not categorized under any group at the present time. Analyzing Nuveen New competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Nuveen New to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Nuveen New Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Nuveen New competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
8.058.378.69
Details
Intrinsic
Valuation
LowRealHigh
8.068.388.70
Details

Nuveen New Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Nuveen New and its competitors represents the degree of relationship between the price movements of corresponding funds. A correlation of about +1.0 implies that the price of Nuveen and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Nuveen New York does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
APAAX
+ 0.73
EVN
444859BR2
+ 0.69
EVN
MSTSX
+ 0.68
LBHIX
SCRYX
+ 0.58
SCRYY
APAAX
+ 0.55
CXH
EVN
+ 0.53
CXH
  
High negative correlations   
SCRYX
- 0.5
444859BR2
SCRYX
- 0.41
EVN
SCRYY
- 0.4
444859BR2
SCRYY
- 0.3
EVN
MSTSX
- 0.13
EVN
MSTSX
- 0.12
444859BR2

Risk-Adjusted Indicators

There is a big difference between Nuveen Fund performing well and Nuveen New Fund doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nuveen New's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CXH  0.34  0.05 (0.17)(0.24) 0.40 
(0.38)
 0.86 
(0.74)
 2.10 
EVN  0.48 (0.01)(0.16) 0.08  0.61 
(0.53)
 1.02 
(1.05)
 2.73 
DTF  0.22 (0.01)(0.40) 0.03  0.24 
(0.27)
 0.36 
(0.36)
 1.96 
444859BR2  0.51 (0.15) 0.00 (1.17) 0.00 
 0.00 
 0.73 
(1.35)
 3.56 
SCRYY  1.97  0.24  0.08  0.61  1.93 
(2.80)
 5.61 
(4.09)
 12.99 
AQUI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
APAAX  0.14  0.00 (0.39) 0.25  0.16 
(0.19)
 0.31 
(0.31)
 1.13 
SCRYX  0.93 (0.01) 0.04  0.12  0.77 
(1.12)
 2.10 
(1.63)
 7.88 
LBHIX  0.12  0.02 (0.44) 1.66  0.00 
(0.28)
 0.24 
(0.24)
 0.96 
MSTSX  0.49  0.04 (0.14)(0.75) 0.52 
(0.61)
 1.21 
(1.02)
 2.80 
All Fundamental Data

Nuveen New Competitive Analysis

The better you understand Nuveen New competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Nuveen New's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Nuveen New's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
NNY CXH EVN DTF 444859BR2 SCRYY AQUI APAAX SCRYX LBHIX
 0.36 
 8.40 
Nuveen
 0.37 
 8.24 
MFS
 0.94 
 10.79 
Eaton
 0.18 
 11.27 
DTF
 1.82 
 80.35 
HUMANA
 1.22 
 2.49 
SCOR
 0.00 
 0.01 
Aquagold
 0.20 
 9.84 
APAAX
 0.27 
 14.98 
Small
 0.24 
 4.26 
Thrivent
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Unstable
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Modest
Weak
Insignificant
Very Weak
OK
Very Weak
Modest
OK
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Very Low
Very Low
Very Low
Below Average
Below Average
Average
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Cautious Hold
Hold
Hold
Strong Sell
Hold
Strong Sell
Cautious Hold
Strong Hold
Strong Sell
Current Ratio
8.81
1.92
2.79
17.99
N/A
9.99
N/A
N/A
N/A
N/A
Net Asset
N/A
114.47 M
617.66 M
84.27 M
N/A
51.52 B
3.19 K
50.97 M
973.72 M
674.44 M
Profit Margin
-1.72
0.29
0.61
0.0647
N/A
-0.0209
N/A
N/A
N/A
N/A
EBITDA
N/A
1.57 M
13.29 M
3.08 M
N/A
1.23 B
(727.69 K)
N/A
N/A
N/A
Price To Book
0.83
0.97
0.96
0.93
N/A
0.67
N/A
N/A
N/A
1.58
Operating Margin
83.58
0.84
0.85
0.7
N/A
-0.0092
N/A
N/A
N/A
N/A
Current Valuation
148.71 M
111.25 M
569.48 M
76.92 M
N/A
4.75 B
912.76 K
N/A
N/A
N/A
Five Year Return
1.02
4.75
4.79
3.64
N/A
4.83
N/A
1.25
10.7
3.46
Retained Earnings
(4.12 M)
(9.58 M)
(36.6 M)
(11.4 M)
N/A
(645.5 M)
(4.18 M)
N/A
N/A
N/A
One Year Return
6.79
N/A
N/A
N/A
N/A
N/A
N/A
7.87
31.82
11.94
Beta
0.19
0.59
0.5
0.32
N/A
1.25
7.05
N/A
N/A
N/A
Number Of Employees
25
N/A
19
19
N/A
3.59 K
7
1
1
1
Cash Position Weight
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.5
1.28
6.56
Equity Positions Weight
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
98.72
0.07
Shares Outstanding
18.89 M
8.2 M
39.67 M
7.03 M
N/A
1.78 B
965.83 K
N/A
N/A
N/A
Three Year Return
-0.45
N/A
N/A
N/A
N/A
N/A
N/A
-0.43
4.27
3.06
Cash Flow From Operations
N/A
11.84 M
71.8 M
43.42 M
N/A
2.41 B
(218.19 K)
N/A
N/A
N/A
Annual Yield
0.0049
0.0368
0.0576
0.0345
N/A
0.0789
N/A
0.003
0.0063
0.0617
Total Debt
N/A
43.77 M
171.29 M
71.88 K
N/A
3.05 B
N/A
N/A
N/A
N/A
Return On Equity
-0.06
0.0216
0.0396
0.0024
N/A
-0.0574
N/A
N/A
N/A
N/A
Bond Positions Weight
N/A
N/A
N/A
N/A
N/A
N/A
N/A
99.5
N/A
92.23
Z Score
N/A
N/A
N/A
N/A
N/A
0.6
N/A
N/A
N/A
N/A
Holdings Turnover
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
1.82
0.0225
0.0245
0.0129
N/A
-0.002
-5.5
N/A
N/A
N/A
Number Of Shares Shorted
15.7 K
53.09 K
70.57 K
37.49 K
N/A
N/A
N/A
N/A
N/A
N/A
Book Value Per Share
10.07
8.46
11.13
12.2
N/A
3.04
-1.18
N/A
N/A
N/A
Minimum Initial Investment
N/A
N/A
N/A
N/A
N/A
N/A
N/A
2.5 K
N/A
2 K
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
794 K
N/A
N/A
N/A
Total Asset
142.55 M
114.47 M
617.66 M
84.27 M
N/A
51.52 B
3.19 K
49.97 M
686.96 M
347.66 M
Last Dividend Paid
0.31
0.28
0.5
0.39
N/A
N/A
N/A
0.02
0.06
0.02
Debt To Equity
0.011
0.62
0.57
0.69
N/A
0.43
N/A
N/A
N/A
N/A
Short Ratio
0.36
3.38
0.63
4.16
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
20.49
37.47
21.03
45.81
N/A
N/A
N/A
N/A
N/A
N/A
Market Capitalization
170.16 M
67.32 M
424.04 M
79.36 M
N/A
4.35 B
96.58 K
N/A
N/A
N/A
Price To Earning
77.04
14.99
11.33
21.4
N/A
12.21
-0.22
N/A
N/A
35.48
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
0.28
N/A
N/A
N/A
N/A
Price To Sales
26.51
12.53
14.81
24.93
N/A
0.2
N/A
N/A
N/A
1.23
Net Income
(102.05 K)
1.57 M
13.29 M
3.08 M
N/A
456 M
(627.79 K)
N/A
N/A
N/A
Earnings Per Share
0.11
0.26
0.44
0.04
N/A
0.25
-0.63
N/A
N/A
N/A
Shares Owned By Insiders
N/A
0.09
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Year To Date Return
2.83
N/A
N/A
N/A
N/A
N/A
N/A
4.0
17.19
7.32
Revenue
5.93 M
1.86 M
15.05 M
3.58 M
N/A
16.03 B
N/A
N/A
N/A
N/A
Working Capital
N/A
N/A
N/A
N/A
N/A
N/A
(794 K)
N/A
N/A
N/A
Ten Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
3.59
N/A
6.0
Cash And Equivalents
3.52 M
1.98 K
4.66 M
111.62 K
N/A
3.52 B
1.15 K
N/A
N/A
N/A
Cash Per Share
0.19
N/A
0.12
0.02
N/A
1.97
N/A
N/A
N/A
N/A
Gross Profit
5.93 M
5.1 M
29.61 M
5.41 M
N/A
(853 M)
(143.88 K)
N/A
N/A
N/A
Day Typical Price
8.4
8.22
10.76
11.29
80.35
2.51
0.006
9.84
14.98
4.26
Accumulation Distribution
281.81
110.83
512.0
11.59
N/A
0.0389
N/A
N/A
N/A
N/A
Market Facilitation Index
0.0
0.0
0.0
0.0
N/A
0.1
N/A
N/A
N/A
N/A
Daily Balance Of Power
0.4286
0.6
1.111111
(0.33)
(9,223,372,036,855)
0.3
0.0
9.2 T
(9,223,372,036,855)
9.2 T
Period Momentum Indicator
0.03
0.03
0.1
(0.02)
(1.49)
0.03
N/A
0.02
(0.04)
0.01
Rate Of Daily Change
1.0
1.0
1.01
1.0
0.98
1.01
1.0
1.0
1.0
1.0
Day Median Price
8.4
8.22
10.75
11.3
80.35
2.52
0.006
9.84
14.98
4.26
Price Action Indicator
0.02
0.04
0.095
(0.04)
(0.75)
(0.01)
N/A
0.01
(0.02)
0.005
Relative Strength Index
45.42
55.9
51.41
63.17
41.32
51.4
N/A
51.62
76.14
79.03
Coefficient Of Variation
(5,225)
989.76
2541.13
2686.61
(654.59)
879.07
N/A
1277.99
722.89
601.89
Mean Deviation
0.2599
0.3423
0.484
0.2189
0.5131
1.97
N/A
0.1374
0.934
0.116
Jensen Alpha
(0.01)
0.0547
(0.01)
(0.01)
(0.15)
0.2413
N/A
0.0031
(0.01)
0.0174
Total Risk Alpha
(0.07)
(0.04)
(0.09)
(0.05)
(0.27)
(0.16)
N/A
(0.03)
(0.05)
(0.01)
Sortino Ratio
N/A
(0.17)
(0.16)
(0.40)
N/A
0.0757
N/A
(0.39)
0.0444
(0.44)
Downside Variance
N/A
0.2887
0.4663
0.0977
N/A
5.52
N/A
0.0962
0.9947
0.0617
Standard Deviation
0.3465
0.4534
0.6454
0.3119
0.8089
2.77
N/A
0.2067
1.32
0.1738
Kurtosis
0.2119
0.8266
0.6977
3.59
10.58
2.24
N/A
4.58
5.42
3.08
Potential Upside
0.7018
0.8642
1.02
0.3594
0.731
5.61
N/A
0.309
2.1
0.2375
Treynor Ratio
1.3
(0.24)
0.081
0.0304
(1.17)
0.6064
N/A
0.2529
0.1224
1.66
Maximum Drawdown
1.67
2.1
2.73
1.96
3.56
12.99
N/A
1.13
7.88
0.9552
Variance
0.1201
0.2056
0.4166
0.0973
0.6543
7.69
N/A
0.0427
1.73
0.0302
Market Risk Adjusted Performance
1.31
(0.23)
0.091
0.0404
(1.16)
0.6164
N/A
0.2629
0.1324
1.67
Risk Adjusted Performance
(0.03)
0.0704
0.0282
0.0139
(0.12)
0.0942
N/A
0.0328
0.1099
0.093
Skewness
0.0313
(0.32)
(0.06)
0.8326
(2.39)
0.8912
N/A
(1.28)
1.53
1.04
Semi Deviation
N/A
0.397
0.606
0.2364
N/A
1.93
N/A
0.158
0.7667
0.0
Information Ratio
(0.42)
(0.20)
(0.17)
(0.40)
(0.32)
0.0641
N/A
(0.59)
0.0337
(0.63)
Value At Risk
(0.59)
(0.74)
(1.05)
(0.36)
(1.35)
(4.09)
N/A
(0.31)
(1.63)
(0.24)
Expected Short fall
N/A
(0.38)
(0.53)
(0.27)
N/A
(2.80)
N/A
(0.19)
(1.12)
(0.28)
Downside Deviation
N/A
0.5373
0.6828
0.3125
N/A
2.35
N/A
0.3101
0.9973
0.2483
Semi Variance
N/A
0.1576
0.3672
0.0559
N/A
3.71
N/A
0.025
0.5878
(0.02)

Nuveen New Competition Performance Charts

Five steps to successful analysis of Nuveen New Competition

Nuveen New's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Nuveen New York in relation to its competition. Nuveen New's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Nuveen New in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Nuveen New's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Nuveen New York, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Nuveen New position

In addition to having Nuveen New in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Power Assets Thematic Idea Now

Power Assets
Power Assets Theme
Large capitalization equities showing high long-term performance indicators and above average return expectations based on Macroaxis rating system. The Power Assets theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Power Assets Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Nuveen Fund

Nuveen New financial ratios help investors to determine whether Nuveen Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nuveen with respect to the benefits of owning Nuveen New security.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY